DD-03-156 ((S,R,S)-AHPC-Me-PEG2-dabrafenib) is a selective small-molecule degrader developed for research use that targets cyclin-dependent kinase 17 (CDK17) and LIM kinase 2 (LIMK2). The compound is provided as a high-purity solid in milligram-scale quantities and is intended for biochemical and cell-based studies with recommended low-temperature storage under inert atmosphere.
- Selective degrader of CDK17 and LIMK2.
- High reported purity suitable for research assays.
- Supplied in milligram-scale quantities for exploratory studies.
- Stable under recommended low-temperature storage when handled under inert atmosphere.
- Includes molecular characterization and CAS registry number for traceability.